Charlotte's Web Holdings (CWBHF) Amortization of Deferred Charges (2021 - 2026)
Charlotte's Web Holdings' (CWBHF) quarterly Amortization of Deferred Charges came in at $114000.0 in Q1 2026, down 75.9% year-on-year from $473000.0 in Q1 2025, and down 50.65% on a QoQ basis from $231000.0 in Q4 2025.
Charlotte's Web Holdings (CWBHF) Amortization of Deferred Charges (2021 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has 6 years of Amortization of Deferred Charges data on file, last reported at $114000.0 in Q1 2026.
- On a quarterly basis, Amortization of Deferred Charges fell 75.9% year-over-year to $114000.0 in Q1 2026; TTM through Mar 2026 was $1.2 million, a 32.26% decrease from a year earlier, with the FY2025 full-year figure at $1.6 million, down 10.84% from the prior year.
- Amortization of Deferred Charges for Q1 2026 stood at $114000.0, down from $231000.0 in the prior quarter.
- Over the last five years, Amortization of Deferred Charges for CWBHF reached as high as $641000.0 in Q3 2022 and fell as low as $114000.0 in Q1 2026.
- Historically, Amortization of Deferred Charges has averaged $442823.5 across 5 years, with a median of $465000.0 in 2023.
- On a YoY basis, Amortization of Deferred Charges climbed as much as 148.97% in 2022 and fell as far as 88.64% in 2022.
- Year by year, Amortization of Deferred Charges stood at $269000.0 in 2022, then soared by 72.86% to $465000.0 in 2023, then decreased by 14.41% to $398000.0 in 2024, then slumped by 41.96% to $231000.0 in 2025, then slumped by 50.65% to $114000.0 in 2026.
- Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $114000.0 in Q1 2026, $231000.0 in Q4 2025, and $398000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Charlotte's Web Holdings | 41.51 Mn | 36.32 Mn | 5.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 114,000.00 |
| Mar 31, 2026 | 114,000.00 |
| Dec 31, 2025 | 231,000.00 |
| Dec 31, 2025 | 231,000.00 |
| Sep 30, 2025 | 398,000.00 |
| Sep 30, 2025 | 398,000.00 |
| Jun 30, 2025 | 477,000.00 |
| Jun 30, 2025 | 477,000.00 |
| Mar 31, 2025 | 473,000.00 |
| Mar 31, 2025 | 473,000.00 |
| Dec 31, 2024 | 398,000.00 |
| Dec 31, 2024 | 398,000.00 |
| Sep 30, 2024 | 465,000.00 |
| Sep 30, 2024 | 465,000.00 |
| Jun 30, 2024 | 465,000.00 |
| Jun 30, 2024 | 465,000.00 |
| Mar 31, 2024 | 443,000.00 |
| Mar 31, 2024 | 443,000.00 |
| Dec 31, 2023 | 465,000.00 |
| Dec 31, 2023 | 465,000.00 |